|
|
|
Neurogen Posts
Q3 Results
|
Business New Haven
11/30/1998
By: BNH
|
BRANFORD - Neurogen Corp. (NASDAQ: NRGN) posted a net loss of $2.8 million, or 20 cents per share, for its third quarter ended September 30 vs. a net loss of $0.9 million (six cents per share) for the same 1997 quarter. Revenues were $2.3 million vs. $3.4 million for the 1997 period. Reduced revenues were the result of the conclusion of research done with Schering-Plough Corp. R&D expenses were $5.3 million, compared to $4.8 million in 1997 quarter due to increases in funding for drug development. As of September 30, cash and marketable securities were $76.9 million, compared to $84.2 million at December 31, 1997.
|
Go FirstGo PreviousGo
NextGo LastGo
to Index
|
|
